Skip to Content

Calvert Emerging Markets Equity A CVMAX Fund Analysis

| Medalist Rating as of | See Eaton Vance Investment Hub

Morningstar’s Analysis CVMAX

Will CVMAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Ceasing Coverage of Calvert Emerging Markets Equity

null Emory Zink

Emory Zink

Analyst Note

Morningstar will cease full analyst coverage of Calvert Emerging Markets Equity on or about Sept. 29, 2023, so our analysts can spend more time researching other strategies. In the future, this strategy will receive an algorithmically assigned Morningstar Medalist Rating. Users should form their own views on this strategy or obtain financial advice.

Published on

Unlock our full analysis with Morningstar Investor